Delivery Order SPE2DB22D3501-SPE2DB24FWA73

Award Date 6/20/24
Potential Completion Date 7/12/24
Potential Value $6.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a $3,108.60 firm fixed-price delivery order contract to supply SPIKEVAX (COVID-19 vaccine) syringes. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense...
The Defense Logistics Agency (DLA) awarded a $70,925.00 firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of SPIKEVAX (COVID-19 vaccine) syringes (0.5 mL) with a completion date of February 21, 2024. This award is part of a larger single-award indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver pharmaceutical products and...
This federal contract award is for the delivery of SPIKEVAX COVID-19 vaccine syringes (0.5 mL) to the U.S. government. The contract, valued at $1,383.94, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00, which serves as the primary vehicle for the company to provide a wide range of...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SPIKEVAX COVID-19 vaccine syringes (0.5 mL) for individuals aged 12 and up. The firm-fixed price delivery order, valued at $17,538.22, has an ultimate completion date of November 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the procurement of SPIKEVAX COVID-19 vaccine syringes. The contract has a firm fixed price of $7,158.90 and an ultimate completion date of December 6, 2024. The contract is classified as a delivery order and is not associated with any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $10,960.00 contract is for the supply of SPIKEVAX COVID-19 vaccine syringes (0.5 mL) for the 12 years and up age group, with a completion date of December 27, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SPIKEVAX (COVID-19) vaccine syringes. The $2,075.91 Firm Fixed Price Delivery Order has an ultimate completion date of August 12, 2024. Amerisourcebergen, as the prime contractor, will be responsible for providing the 0.5 mL vaccine syringes to support the government's COVID-19 vaccination efforts. This award is not associated with a...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp for the supply of SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML syringes. This $6,985.70 firm-fixed-price contract has a completion date of September 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, will provide these medical supplies to support federal healthcare programs and military treatment facilities nationwide. The contract is not set aside and is issued under a larger, up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of SPIKEVAX COVID-19 vaccine syringes (0.5 mL) in support of the 2023-2024 vaccination program for individuals aged 12 and above. The contract, valued at $4,662.84, is a firm fixed-price delivery order with an ultimate completion date of October 18, 2023. The award was not designated with a set-aside requirement, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SPIKEVAX COVID-19 vaccine syringes (0.5 mL) for individuals aged 12 and up. The firm-fixed-price delivery order, valued at $4,662.90, has an ultimate completion date of December 19, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWA73
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SPIKEVAX COVID-19 vaccine syringes valued at $6,919.70. This contract has an ultimate completion date of July 12, 2024 and is a firm fixed-price arrangement. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to the Department of Defense globally. The current award is not designated as a small business set-aside.

Generated 9/19/24, 9:05 AM